Dirk-Jan van Beek

Dirk-Jan van Beek

Auto-generated profile, based on publicly available information

Dirk-Jan van Beek

Department of Endocrine Surgical Oncology, University Medical Center Utrecht, Utrecht, The Netherlands

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 July 2018 in Journal of the Endocrine Society
Verified
Journal Article
Open access
PDF file
MTMark J C van Treijen
Mark J C van Treijen
DBDirk-Jan van Beek
Dirk-Jan van Beek
RLRachel S van Leeuwaarde
Rachel S van Leeuwaarde
MVMenno R Vriens
Menno R Vriens
GVGerlof D. Valk
Gerlof D. Valk
In multiple endocrine neoplasia type 1 (MEN1) non-functional pancreatic neuroendocrine tumors (NF-pNETs) are the most frequent diagnosed neuroendocrine tumors (NETs) and a leading cause of MEN1-related death. The high prevalence and malignant potential of NF-pNETs outline the need for an evidenced based screening program since early diagnosis and timely intervention could reduce morbidity and mortality. Controversies exist regarding the value of several diagnostic tests. This systematic review aims to evaluate current literature and amplify an up-to-date evidence based approach to NF-pNET diagnosis in MEN1. Three databases were systematically searched on the diagnostic value of biomarkers and imaging modalities. Twenty-seven studies were included and critically appraised (modified Quadas-2). Another 12 studies providing data on age-related penetrance and tumor growth were included to assess the optimal frequency and timing of screening. Based on current literature, biomarkers should no longer play a role in the diagnostic process for NF-pNETs since accuracies are too low. Studies evaluating the diagnostic value of imaging modalities are heterogeneous with varying risks of bias. For the detection of NF-pNETs, EUS has the highest sensitivity. A combined strategy of EUS and MRI seems to be the most useful. 68Ga-DOTA PET-CT could be added if NF-pNETs are diagnosed to identify metastasis. Reported growth rates were generally low and two distinct phenotypes were observed. Surveillance programs should focus on and be adapted to the presence of significant growth in NF-pNETs. The optimal age to start screening must yet be determined since insufficient evidence for an evidence based recommendation was available.

1 July 2015 in Medicine
Verified
Journal Article
Open access
WKWouter P. Kluijfhout
Wouter P. Kluijfhout
DBDirk-Jan van Beek
Dirk-Jan van Beek
ASAnnemarie A. Verrijn Stuart
Annemarie A. Verrijn Stuart
LLLutske Lodewijk
Lutske Lodewijk
GVGerlof D. Valk
Gerlof D. Valk
IRInne H.M. Borel Rinkes
Inne H.M. Borel Rinkes
The aim of this study was to investigate whether younger age at surgery is associated with the increased incidence of postoperative complications after prophylactic thyroidectomy in pediatric patients with multiple endocrine neoplasia (MEN) 2. The shift toward earlier thyroidectomy has resulted in significantly less medullary thyroid carcinoma (MTC)-related morbidity and mortality. However, very young pediatric patients might have a higher morbidity rate compared with older patients. Hardly any literature exists on complications in the very young. A retrospective single-center analysis was performed on the outcomes of MEN2 patients undergoing a prophylactic total thyroidectomy at the age of 17 or younger. Forty-one MEN2A and 3 MEN2B patients with thyroidectomy after January 1993 and at least 6 months of follow-up were included, subdivided in 9 patients younger than 3 years, 15 patients 3 to 6 years, and 20 patients older than 6 years. Postoperative hypocalcemia and other complications were registered. Twelve (27%) patients developed transient hypocalcemia and 9 (20%) patients suffered from permanent hypocalcemia, with a nonsignificant trend toward higher incidence with decreasing age. Three (7%) patients had other complications, of whom 2 were younger than 3 years. For patients younger than 3 years, the average length of stay (LOS) was 6.7 days, versus 1.7 and 3.5 days, respectively, for the older patient groups (P < 0.05). Patients with complications had a longer LOS compared with patients without (5.0 vs 2.0, P < 0.01). None of the patients had clinical signs of recurrent MTC after a mean follow-up of 10.5 years. Prophylactic thyroidectomy in very young children is associated with a higher rate of complications, causing a significant increased LOS. Irrespective age of surgery, MTC did not recur in any patient. In planning optimal timing of surgery, clinicians should take the risk of complications into account. We advise not to perform total thyroidectomy before the age of 3 for patients defined high risk by the American Thyroid Association guideline.

24 March 2022 in Surgery
Verified
Journal Article
Open access
DBDirk-Jan van Beek
Dirk-Jan van Beek
TTTim J. Takkenkamp
Tim J. Takkenkamp
EWEdgar M. Wong-Lun-Hing
Edgar M. Wong-Lun-Hing
RKRuben H.J. de Kleine
Ruben H.J. de Kleine
AWAnnemiek M.E. Walenkamp
Annemiek M.E. Walenkamp
MVMenno R. Vriens
Menno R. Vriens
Surgical resection is the only potentially curative treatment for pancreatic neuroendocrine tumors. The choice for the type of procedure is influenced by the expected oncological benefit and the anticipated risk of procedure-specific complications. Few studies have focused on complications in these patients. This cohort study aimed to assess complications and risk factors after resections of pancreatic neuroendocrine tumors. Patients undergoing resection of a pancreatic neuroendocrine tumor were identified within 2 centers of excellence. Complications were assessed according to the Clavien-Dindo classification and the comprehensive complication index. Logistic regression was performed to compare surgical procedures with adjustment for potential confounders (Clavien-Dindo ≥3). The cohort comprised 123 patients, including 12 enucleations, 50 distal pancreatectomies, 51 pancreatoduodenectomies, and 10 total/combined pancreatectomies. Mortality was 0.8%, a severe complication occurred in 41.5%, and the failure-to-rescue rate was 2.0%. The median comprehensive complication index was 22.6 (0-100); the comprehensive complication index increased after more extensive resections. After adjustment, a pancreatoduodenectomy, as compared to a distal pancreatectomy, increased the risk for a severe complication (odds ratio 3.13 [95% confidence interval 1.32-7.41]). Of the patients with multiple endocrine neoplasia type 1 or von Hippel-Lindau, 51.9% developed a severe complication vs 38.5% with sporadic disease. After major resections, morbidity was significantly higher in patients with multiple endocrine neoplasia type 1/von Hippel-Lindau (comprehensive complication index 45.1 vs 28.9, P = .029). Surgery for pancreatic neuroendocrine tumors is associated with a high rate of complications but low failure-to-rescue in centers of excellence. Complications are procedure-specific. Major resections in patients with multiple endocrine neoplasia type 1/von Hippel-Lindau appear to increase the risk of complications.

1 July 2019 in Surgery
Verified
Journal Article
Closed access
SCSabrina Chiloiro
Sabrina Chiloiro
DBDirk-Jan van Beek
Dirk-Jan van Beek
EPEmily L. Postma
Emily L. Postma
WSWilko Spiering
Wilko Spiering
IRInne H.M. Borel Rinkes
Inne H.M. Borel Rinkes
SKSchelto Kruijff
Schelto Kruijff

10 August 2019 in Journal of Surgical Oncology
Verified
Journal Article
Open access
PDF file
DBDirk‐Jan van Beek
Dirk‐Jan van Beek
SNSjoerd Nell
Sjoerd Nell
CPCarolina R.C. Pieterman
Carolina R.C. Pieterman
WHWouter W. de Herder
Wouter W. de Herder
AVAnnenienke C. van de Ven
Annenienke C. van de Ven
GVGerlof D. Valk
Gerlof D. Valk
Background and objectives: Gastrinomas are the most prevalent functioning neuroendocrine tumors (NET) in multiple endocrine neoplasia type 1 (MEN1). Guidelines suggest medical therapy in most patients, but surgery may be considered in a subgroup. Currently, factors to guide management are necessary. This population‐based cohort study assessed prognostic factors of survival in patients with MEN1‐related gastrinomas.Methods: Patients with MEN1 having gastrinomas were identified in the Dutch MEN1 database from 1990 to 2014 based on fasting serum gastrin (FSG) levels and/or pathology. Predictors of overall survival were assessed using Cox regression.Results: Sixty‐three patients with gastrinoma (16% of the MEN1 population) were identified. Five‐ and 10‐year overall survival rates were 83% and 65%, respectively. Prognostic factors associated with overall survival were initial FSG levels ≥20x upper limit of normal (ULN) (hazard ratio [HR], 6.2 [95% confidence interval, 1.7‐23.0]), pancreatic NET ≥2 cm (HR 4.5; [1.5‐13.1]), synchronous liver metastases (HR 8.9; [2.1‐36.7]), gastroduodenoscopy suspicious for gastric NETs (HR 12.7; [1.4‐115.6]), and multiple concurrent NETs (HR 5.9; [1.2‐27.7]).Conclusion: Life expectancy of patients with MEN1 gastrinoma is reduced. FSG levels and pancreatic NETs ≥2 cm are prognostic factors. FSG levels might guide surveillance intensity, step‐up to additional diagnostics, or provide arguments in selecting patients who might benefit from surgery.

31 January 2021 in Annals of Surgical Oncology
Verified
Journal Article
Open access
PDF file
DBDirk-Jan van Beek
Dirk-Jan van Beek
SNSjoerd Nell
Sjoerd Nell
WVWessel M. C. M. Vorselaars
Wessel M. C. M. Vorselaars
BBBert A. Bonsing
Bert A. Bonsing
CECasper H. J. van Eijck
Casper H. J. van Eijck
MVMenno R. Vriens
Menno R. Vriens
Background: Little is known about complications after major duodenopancreatic surgery for duodenopancreatic neuroendocrine tumors (dpNETs) in multiple endocrine neoplasia type 1 (MEN1). Therefore, the incidence and severity of complications after major surgery for MEN1-related dpNETs were assessed. Methods: Patients were selected from the population-based Dutch MEN1 database if they had undergone a Whipple procedure or total pancreatectomy from 2003 to 2017. Complications were graded according to the Clavien–Dindo classification (grade III or higher complications were considered a severe complication) and definitions from the International Study Group of Pancreatic Surgery. The Cumulative Complication Index (CCI®) was calculated as the sum of all complications weighted for their severity. Univariable logistic regression was performed to assess potential associations between predictor candidates and a severe complication. Results: Twenty-seven patients (median age 43 years) underwent a major duodenopancreatic resection, including 14 Whipple procedures and 13 total pancreatectomies. Morbidity and mortality were 100% (27/27) and 4% (1/27), respectively. A severe complication occurred in 17/27 (63%) patients. The median CCI® was 47.8 [range 8.7–100]. Grade B/C pancreatic fistulas, delayed gastric emptying, bile leakage, hemorrhage, and chyle leakage occurred in 7/14 (50%), 10/27 (37%), 1/27 (4%), 7/27 (26%), 3/27 (11%) patients, respectively. Patients with a severe complication had longer operative time and higher blood loss. After Whipple, new-onset endocrine and exocrine insufficiency occurred in 1/13 and 9/14 patients, respectively. Conclusions: Major duodenopancreatic surgery in MEN1 is associated with a very high risk of severe complications and cumulative burden of complications and should therefore be reserved for a select subgroup of patients with MEN1-related dpNETs.